Welcome to our dedicated page for The Oncology Institute news (Ticker: TOI), a resource for investors and traders seeking the latest updates and insights on The Oncology Institute stock.
The Oncology Institute Inc (TOI) delivers community-focused cancer care through innovative treatment models and value-based services. This page serves as the definitive source for official company announcements, financial updates, and strategic developments.
Access real-time updates on TOI's clinical trial advancements, partnership agreements, and operational milestones. Investors will find earnings reports, leadership updates, and market-moving news consolidated for efficient analysis. Media professionals can track press releases detailing TOI's expansion of outpatient services and community health initiatives.
Key content categories include quarterly financial disclosures, research collaborations, care model innovations, and regulatory developments. All materials are sourced directly from TOI's corporate communications, ensuring accuracy and timeliness.
Bookmark this page for streamlined access to TOI's evolving story in oncology care. Check regularly for updates that matter to stakeholders monitoring the intersection of healthcare innovation and value-based treatment delivery.
The Oncology Institute of Hope and Innovation (TOI) has expanded its presence in Southern California by opening a new clinic in Culver City on March 7, 2022, and enhancing its Riverside location on March 14, 2022. These expansions aim to improve access to quality oncology care. The Culver City clinic provides comprehensive medical services while the Riverside clinic tripled its infusion space to accommodate a growing patient population. TOI's commitment to advancing cancer care includes a strong emphasis on clinical trials and outpatient services, benefiting both patients and clinicians.
The Oncology Institute (NASDAQ: TOI) reported record revenue of $203 million for 2021, reflecting an 8.3% increase year-over-year.
For Q4, revenue reached $52 million, a 6.8% increase, despite a net loss of $10 million and significant SG&A expenses of $48 million due to growth investments.
Looking ahead to 2022, TOI anticipates revenue of $270 million to $310 million and projects managing between 1.75 million to 2.0 million lives under value-based contracts.
CERRITOS, Calif., March 8, 2022 – The Oncology Institute of Hope and Innovation (NASDAQ: TOI) announced that CEO Brad Hively will participate in the Jefferies Value-Based Healthcare Summit in Miami on March 14 at 1:40 pm EST. Hively has over 20 years of healthcare experience, transforming TOI into a leading oncology provider with over 50 clinics nationwide. The institute offers innovative, value-based cancer care to approximately 1.6 million patients. Investors can access a webcast of the event on the company’s website.
The Oncology Institute of Hope and Innovation (NASDAQ: TOI) has announced the promotions of Dr. Daniel Virnich to President and Dr. Matt Miller to Chief Operating Officer, effective March 15, 2022. These changes are part of a response to TOI's rapid growth. Dr. Virnich, who joined in 2020, will oversee various functions including Operations and Compliance, while Dr. Miller will manage all field and central operations nationally. Both leaders have previously driven tangible improvements in operational efficiency and patient satisfaction, positioning TOI for continued development in specialized oncology care.
The Oncology Institute (TOI) has established a value-based agreement with MaxHealth to deliver medical oncology care in Pinellas and Hillsborough Counties, beginning March 1, 2022. This partnership aims to enhance patient care through TOI's innovative oncology model, which includes over 170 clinical trials and comprehensive oncology services. The initiative targets expansion into neighboring counties, reflecting TOI's commitment to improving cancer care accessibility. Both organizations emphasize a shared goal of personalized patient care and satisfaction.
The Oncology Institute of Hope and Innovation (TOI) has entered a value-based agreement with MaxHealth to provide medical oncology care in Pinellas and Hillsborough Counties, Florida. This partnership, effective from March 1, 2022, aims to enhance cancer care access and quality through community-focused services, including clinical trials and stem cell transplants. TOI plans to expand this initiative to neighboring counties shortly. Both organizations emphasize a commitment to personalized care and improving patient satisfaction.
The Oncology Institute (TOI) will release its fourth quarter and full year results on March 10, 2022, after market close. Following the results, a conference call is scheduled for 5:00 p.m. ET, accessible via phone or webcast. TOI specializes in delivering advanced, value-based cancer care to over 1.5 million patients, with 54 clinic locations and a team of 80+ clinicians. Their services include clinical trials, stem cell transplants, and transfusions. Interested parties can join the call and access a replay through the provided contact information.
The Oncology Institute of Hope and Innovation (NASDAQ: TOI) has expanded its footprint by opening its 54th clinic in Lakeland, Florida, enhancing oncology services available in Polk County. This new clinic, which is the sixth in Florida, aims to provide patients with convenient access to oral chemotherapeutics and blood transfusion services. With experienced providers onboard, the institute continues to showcase its commitment to value-based cancer care. The expansion aligns with TOI's efforts to elevate healthcare standards and meet growing patient needs in the region.
TOI has expanded its physician network by acquiring the practices of Dr. Ellsworth R. Grant and Dr. Leo E. Orr, adding to its team of over 80 clinicians. This acquisition will enhance TOI's ability to provide value-based oncology care to more than 1.5 million patients across its locations.
The new facility in Westlake offers advanced medical services similar to other TOI clinics, enhancing patient access to high-quality cancer care.
FAQ
What is the current stock price of The Oncology Institute (TOI)?
What is the market cap of The Oncology Institute (TOI)?
